What does it mean if Hepatitis B (HB) surface antibody (HBsAb) is reactive, HB surface antigen (HBsAg) is non-reactive, and HB core total antibody (HBcAb) is non-reactive?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hepatitis B Serologic Pattern: Immunity from Vaccination

Your serologic pattern (HBsAg non-reactive, HBsAb reactive, HBcAb non-reactive) indicates immunity to hepatitis B virus from successful vaccination. 1, 2

What This Pattern Means

  • You are immune to hepatitis B infection through vaccination rather than natural infection, as confirmed by the presence of HBsAb without HBcAb. 1, 3

  • You are not currently infected with hepatitis B virus, as evidenced by the negative HBsAg. 1, 2

  • You cannot transmit hepatitis B to others because you have no active infection. 2

  • You have never had a natural hepatitis B infection, which is distinguished by the absence of HBcAb (core antibody). 3 The presence of HBsAb alone, without HBcAb, specifically indicates vaccine-derived immunity rather than immunity from past infection. 3

Clinical Significance

  • Protective immunity is confirmed when HBsAb levels are ≥10 mIU/mL, which is the threshold used by commercial assays to indicate protection. 3

  • No treatment or vaccination is needed because you already have protective immunity. 1, 2

  • This immunity is durable due to immunologic memory that persists even if antibody levels decline over time. 4 Studies demonstrate that vaccine-induced memory B lymphocytes continue to provide protection for 5-12 years or longer, even when antibody levels fall below detectable thresholds. 4

Special Considerations for Immunosuppression

  • If you require immunosuppressive therapy (such as chemotherapy, anti-CD20 monoclonal antibodies like rituximab, or high-dose corticosteroids), you should be monitored for potential loss of immunity. 1, 2

  • HBV reactivation risk is minimal in your case because you lack HBcAb, meaning you have no prior natural infection that could reactivate. 1, 5 The 3-45% reactivation risk applies specifically to patients who are HBcAb-positive, not to those with vaccine-derived immunity alone. 1, 3

  • Routine booster vaccination is not recommended for healthy individuals with vaccine-derived immunity, as immunologic memory provides ongoing protection independent of measurable antibody levels. 4

When Additional Testing May Be Needed

  • Periodic monitoring of HBsAb levels may be considered if you are a healthcare worker or have ongoing high-risk exposures to hepatitis B. 2

  • Postvaccination testing would have been indicated if you had chronic liver disease or advanced immunosuppression at the time of vaccination, due to lower seroconversion rates in these populations. 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Interpretation of Hepatitis B and C Serology Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hepatitis B Surface Antigen and Antibody Interpretation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Interpretation of Hepatitis B Surface Antigen Non-reactive & Reactive Hepatitis B Core Antibody

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the management plan for a patient who is Hepatitis B surface antigen (HBsAg) positive and Hepatitis B surface antibody (HBsAb) positive?
What is the recommended treatment and management plan for an individual with hepatitis B core reactive status and mild hyperbilirubinemia?
What are the management and treatment recommendations for a 19-year-old patient with a reactive Hepatitis B (Hep B) core antibody and non-reactive Hepatitis B surface antigen?
What is the management plan for a 54-year-old male with elevated liver enzymes (hypertransaminasemia), hypercholesterolemia, and a history of past hepatitis B infection (as indicated by positive Hepatitis B core antibody (HBcAb) total and normal Hepatitis B surface antibody (HBsAb) levels) and negative Hepatitis B surface antigen (HBsAg)?
What is the best Hepatitis B (HBV) screening strategy for a general population without specific risk factors?
What is the workup for a patient with vaginal bleeding and anemia requiring blood transfusion but has incompatible crossmatches with available blood units?
What is the calculation and clinical significance of Systemic Vascular Resistance (SVR)?
What is the role of transfusion in managing sickle cell disease?
Is intraoperative neuromonitoring (IONM) medically necessary for a patient with moderate thoracolumbar spondylosis and severe stenosis undergoing spinal surgery?
What are the management options for Gestational Diabetes Mellitus (GDM)?
What is the optimal management for a 35-year-old woman with Stage IIIA HER2-positive breast cancer?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.